Marshall Stanton sells shares; AORT notifies restricted vesting (AORT)

Rhea-AI Filing Summary

AORT insider filings report proposed and completed transactions in common stock. The filing lists a restricted stock vesting of 1,513 shares on 02/27/2026 described as issuer compensation. It also reports past sales by Marshall S. Stanton of 2,423 shares for $91,074.51 on 02/23/2026 and 1,259 shares for $44,937.36 on 02/24/2026.

Insights

Corporate Governance Expert

Filing records restricted stock vesting and recent insider sales by a named officer.

The excerpt shows a restricted stock vesting event of 1,513 shares on 02/27/2026 characterized as issuer compensation. It separately documents completed sales by Marshall S. Stanton of 2,423 shares for $91,074.51 on 02/23/2026 and 1,259 shares for $44,937.36 on 02/24/2026.

These entries are routine compensation vesting and reported dispositions; cash‑flow treatment to the issuer versus selling holders is explicit for the sales amounts shown. Subsequent filings or transaction confirmations may provide additional context such as brokerage details or whether the vested shares were subject to lockups.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1513	57531.67	47883897	03/02/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/27/2026	Restricted Stock Vesting	Issuer			1513	02/27/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Marshall S. Stanton 1655 Roberts Boulevard N.W. Kennesaw GA 30144	Common	02/23/2026	2423	91074.51
Marshall S. Stanton 1655 Roberts Boulevard N.W. Kennesaw GA 30144	Common	02/24/2026	1259	44937.36

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the AORT Form 144 disclose about restricted stock?

The filing discloses a restricted stock vesting of 1,513 shares on 02/27/2026 described as issuer compensation. This line identifies the issuance event; the filing does not state further sale timing or proceeds for those vested shares.

How many shares did Marshall S. Stanton sell according to the AORT filing?

The filing reports two sales by Marshall S. Stanton: 2,423 shares for $91,074.51 on 02/23/2026 and 1,259 shares for $44,937.36 on 02/24/2026. These amounts are recorded as past sales.

Does the Form 144 indicate who received proceeds from the transactions?

The filing lists sale amounts tied to the reported sales by Marshall S. Stanton, showing proceeds of $91,074.51 and $44,937.36. It does not state alternative recipients; proceeds attribution follows the named seller entries in the excerpt.

Is the planned sale amount or offering size specified in the AORT excerpt?

The excerpt specifies a vesting of 1,513 shares on 02/27/2026 and two completed sales by the named individual. It does not present an aggregate offering size or a registration amount in the provided content.